FLIXOTIDE

Pressurised inhalation, suspension, 125mcg/doza
RxActive license

Active substance (INN)

fluticasone

Pharmaceutical form

Pharmaceutical formPressurised inhalation, suspension
Strength125mcg/doza
PackagingUkupno 1 kontejner pod pritiskom (1x60 doza) u kartonskoj kutiji
ManufacturerGlaxo Wellcome S.A., Spain
Therapeutic groupRespiratory system (R03BA05)
Marketing authorization holder"EVROPA LEK PHARMA" DOO PODGORICA
Authorization dateApril 11, 2023

Analogs in Montenegro

9

Other medicines with the same active substance

AIRFLUSAL® FORSPIRO®Rx
Inhalation powder, pre-dispensed, 50mcg + 250mcgAeropharm GmbH
AIRFLUSAL® FORSPIRO®Rx
Inhalation powder, pre-dispensed, 50mcg + 500mcgAeropharm GmbH
DYMISTARx
Nasal spray, suspension, 50mcg/doza + 137mcg/dozaMEDA Pharma GmbH & Co.KG
FLIXOTIDERx
Pressurised inhalation, suspension, 50mcg/dozaGlaxo Wellcome S.A.
FLIXOTIDERx
Pressurised inhalation, suspension, 250mcg/dozaGlaxo Wellcome S.A.
FLUFETANRx
Nasal spray, suspension, 50mcg/doza + 137mcg/dozaElpen Pharmaceutical Co.
SERETIDE DISKUSRx
Inhalation powder, pre-dispensed, 50mcg/doza + 100mcg/dozaGlaxo Wellcome Production
SERETIDE DISKUSRx
Inhalation powder, pre-dispensed, 50mcg/doza + 250mcg/dozaGlaxo Wellcome Production
SERETIDE DISKUSRx
Inhalation powder, pre-dispensed, 50mcg/doza + 500mcg/dozaGlaxo Wellcome Production
Source: CInMED register